SCHEMBL5951552

SCHEMBL5951552

C[Sn](C)(C)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.61
LMNA P02545 2/20 0.61
ACHE P22303 1/20 0.57
ALDH1A1 P00352 6/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALOX15 P16050 1/20 0.52
HSP90AA1 P07900 1/20 0.50
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NFE2L2 Q16236 2/20 0.46
CA2 P00918 1/20 0.46
CA5A P35218 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11800582 0.78 TSHR (0.59) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL36632 0.78 TSHR (1.00) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL29291896 0.78 TSHR (1.00) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL27624202 0.76 TSHR (0.85) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL28052990 0.76 TSHR (0.85) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL28274996 0.76 TSHR (0.85) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL27442892 0.76 TSHR (0.85) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL9733868 0.75 TSHR (0.94) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL11661349 0.75 TSHR (0.94) TSHRLMNAACHEALDH1A1TDP1
Dinitrophenylene SCHEMBL2997371 0.75 TSHR (0.94) TSHRLMNAACHEALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A TSHR 4624/4885LMNA 1082/4885ACHE 839/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 TSHR 4667/4885LMNA 1251/4885ACHE 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.